Lifecore Biomedical, Inc. (LFCR)
NASDAQ · Healthcare
Lifecore Biomedical, Inc. EBITDA 2010–2025
Lifecore Biomedical, Inc. annual/quarterly ebitda history and growth rate from 2010 to 2025. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Lifecore Biomedical, Inc. ebitda for the quarter ending September 30, 2025 was -1.1 M.
- Lifecore Biomedical, Inc. ebitda for the twelve months ending September 30, 2025 was -17.5 M, a 367.74% increase year-over-year.
- Lifecore Biomedical, Inc. annual ebitda for 2025 was -9.2 M, a 935.73% increase from 2024.
- Lifecore Biomedical, Inc. annual ebitda for 2024 was -890000, a 89.67% decrease from 2023.
- Lifecore Biomedical, Inc. annual ebitda for 2023 was -8.6 M, a 237.46% decrease from 2022.
- Lifecore Biomedical, Inc. annual ebitda for 2022 was 6.3 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Lifecore Biomedical, Inc. EBITDA — FAQ
Lifecore Biomedical, Inc. (LFCR) ebitda over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LFCR's ebitda history?
The chart and table above show Lifecore Biomedical, Inc.'s ebitda by year and by quarter, including the growth rate.